The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001

Clinical Infectious Diseases

Volumn 45, Issue 7, 2007, Pages 881-882

  Whitley, Richard J ^a,b,c,d   Gnann, John W ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID; VIDARABINE;

ANTIVIRAL ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INCIDENCE; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWEDEN; VIRUS REPLICATION; HERPES SIMPLEX VIRUS; MORTALITY; PATHOGENICITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ACYCLOVIR; ANTIVIRAL AGENTS; ENCEPHALITIS, HERPES SIMPLEX; HUMANS; INCIDENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SIMPLEXVIRUS; SWEDEN;

EID: 34848850098     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/521261     Document Type: Note

References (5)

1. Hjalmarsson A, Blomqvist P, Sköldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 2007; 45:875-80 (in this issue).
2. Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Chien LT, Alford CA; The Collaborative Study Group. Adenine arabinoside therapy of biopsyproven herpes simplex encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study. N Engl J Med 1977; 297:289-94.
3. Skoldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis: randomised multicentre study in consecutive Swedish patients. Lancet 1984; 2:707-11.
4. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986; 314:144-9.
5. Sergerie Y, Boivin G, Gosselin D, Rivest S. Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. JID 2007; 195:817-25.